Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
02/2009
02/12/2009US20090042950 Silicone to adjust release profile of active materials; topical applying to skins with penetration promoter and volatile solvent
02/12/2009US20090042799 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction
02/12/2009US20090042791 Integrin binding motif containing peptides and methods of treating skeletal diseases
02/12/2009US20090042777 G-CSF Transferrin Fusion Proteins
02/12/2009US20090042252 Interferon-alpha polypeptides and conjugates
02/12/2009US20090041872 Encapsulated Vaccinium Extracts with Balanced Gastrointestinal Release
02/12/2009US20090041848 Skin anti-aging agent for external use
02/12/2009US20090041842 Partly Neutralised Anionic (Meth) Acrylate Copolymer
02/12/2009US20090041840 Positive wakeup pharmaceutical sleep system with compatible pre-bedtime administration
02/12/2009US20090041832 Adhesive mixture for transdermal delivery of highly plasticizing drugs
02/12/2009US20090041828 Insert for the treatment of dry eye
02/12/2009US20090041827 Therapeutic Microfoam
02/12/2009US20090041824 Method and apparatus for composite drug delivery medical devices
02/12/2009US20090041820 Functional polymer compositions
02/12/2009US20090041813 Active substance composition comprising at least one nitrogen atom-containing, hyperbranched polymer
02/12/2009US20090041811 Oil-In-Water Emulsion Composition
02/12/2009US20090041809 Double-stranded locked nucleic acid compositions
02/12/2009US20090041791 for linking drug moieties to ligands; comprises a peptide sequence that is a substrate for an intracellular enzyme, for example a cathepsin, that cleaves the peptide at an amide bond
02/12/2009US20090041730 Joint Repair Using Mesenchymal Stem Cells
02/12/2009US20090041714 Polymer-factor VIII moiety conjugates
02/12/2009US20090041697 Film-Forming Compositions for Protecting Skin From Body Fluids and Articles Made Therefrom
02/12/2009US20090041685 Cosmetic Delivery System and Process for Manufacture Thereof
02/12/2009US20090041665 Method for gene delivery to neuronal cells
02/12/2009DE10064219B9 Neue Fentanyl und/oder dessen Derivate enthaltende pharmazeutische Zusammensetzung zur nasalen Anwendung New fentanyl and / or its derivatives containing pharmaceutical composition for nasal administration
02/12/2009CA2702711A1 Liquid preparation containing herb and/or animal-origin extract
02/12/2009CA2699461A1 Inhibitors of intracellular urokinase plasminogen activator and methods of use thereof
02/12/2009CA2698752A1 Oral cannabinoid liquid formulations and methods of treatment
02/12/2009CA2696303A1 Chlorotoxins as drug carriers
02/12/2009CA2695991A1 Immunoliposome inducing apoptosis into cell expressing death domain-containing receptor
02/12/2009CA2695901A1 Nucleic acid-lipopolymer compositions
02/12/2009CA2695830A1 Transferrin variants and conjugates
02/12/2009CA2694061A1 Gel composition for external application containing an adenine compound
02/12/2009CA2665690A1 Propylene glycol hyaluronate, and skincare preparation for external use comprising same
02/11/2009EP2022853A1 Freeze-dried product for transferring nucleic acid, oligonucleic acid or derivative thereof
02/11/2009EP2022850A1 Flavin adenine dinucleotide-binding glucose dehydrogenase
02/11/2009EP2022799A2 Polycistronic expression of antibodies
02/11/2009EP2022497A1 Oral composition comprising 3-[5-[4-(cyclopentyloxy) -2-hydroxybenzoyl]-2-](3-hydroxy-1,2-benzisoxazol-6- yl)methoxy¨phenyl¨propionic acid or salt thereof
02/11/2009EP2022494A2 Laxative preparation containing l-Arginine
02/11/2009EP2021797A2 Compositions of n-ý2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl¨-1,4-dihydro-4-oxoquinoline-3-carboxamide
02/11/2009EP2021374A1 Biocompatible three dimensional matrix for the immobilization of biological substances
02/11/2009EP2021032A1 Peg-modified arginine/lysine oxidoreductase
02/11/2009EP2021031A1 Hydrogel sheet and production method thereof
02/11/2009EP2021030A2 Buffering agents for biopharmaceutical formulations
02/11/2009EP2021024A1 Nicotine-carrier vaccine formulation
02/11/2009EP2020998A1 Compositions and methods for the inhibition of endothelial nitric oxide synthase activity
02/11/2009EP2020991A2 A direct cellular energy delivery system
02/11/2009EP2020989A2 Pulmonary delivery of 1,25-dihydroxyvitamin d3 and co-administration of parathyroid hormone or calcitonin
02/11/2009EP2020987A1 Sol-gel nanostructured titania reservoirs for use in the controlled release of drugs in the central nervous system and method of synthesis
02/11/2009EP1747262A4 Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates
02/11/2009EP1487484B1 Use of mixtures of lipopeptides for vaccine production
02/11/2009EP1480687B1 Modified phosphocalcic compound, injectable composition containing same
02/11/2009EP1317258B1 Use of allopurinol for the treatment of hypertension
02/11/2009CN101365671A Isohumulone compound clathrate and composition containing the same
02/11/2009CN101365493A Keratin-binding effector molecules, and method for the production thereof
02/11/2009CN101365492A Transglutaminase mediated conjugation of growth hormone
02/11/2009CN101365491A Particulate lipid pharmaceutical composition
02/11/2009CN101365490A Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same
02/11/2009CN101365489A Method for deriving a wellness related index for a food composition
02/11/2009CN101365433A Iontophoresis preparation
02/11/2009CN101365432A Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin
02/11/2009CN101365426A Pre-compacted calcium-containing compositions
02/11/2009CN101365424A Methods for affecting liposome composition by ultrasound irradiation
02/11/2009CN101365423A Sustained release small molecule drug formulation
02/11/2009CN101363028A Complementary type high capacity adenoviral vector and vaccine and gene therapy producers constructed by the same
02/11/2009CN101361982A Preparation method of folacin coupled chitosan
02/11/2009CN101361981A Preparation method of nano material suitable for infrared-light targeted therapy of cancer
02/11/2009CN101361980A Heparin phospholipid composite suitable for non-injection administration and preparation method thereof
02/11/2009CN101361979A Solid preparation film coating agent and preparation method thereof
02/11/2009CN101361978A Anti-cancer medicine release system using cellular membrane biomimetic modification polyamide-amide as carrier and preparation method thereof
02/11/2009CN101361977A Drug-loaded biodegradable shape memory macromolecule composite material and preparation method thereof
02/11/2009CN101361976A Hyaluronic acid modified polu-cyano acrylic acid alkyl ester nano granules and preparation method and use thereof
02/11/2009CN101361975A Medical plaster hot-melt adhesive ground substance, traditional Chinese medicine plaster using the ground substance and preparation method thereof
02/11/2009CN101361969A Therapeutic hepatitis b vaccine and preparation method and use thereof
02/11/2009CN101361963A Preparation method of protein and peptide drugs slow-release microcapsules
02/11/2009CN101361887A Traditional Chinese medicine formulation for treating dermatopathy
02/11/2009CN101361829A Traditional Chinese medicine for treating rheumatism, atrophic arthritis and preparation method thereof
02/11/2009CN101361804A Enteral nutrition emulsion for tumor patient
02/11/2009CN101361767A Medicine for relieving cough, eliminating sputum, relieving dyspepsia, promoting blood and dissipating blood stasis and preparation method thereof
02/11/2009CN101361763A Pollen hormone freeze dehydration method
02/11/2009CN101361762A Spray-draying method of pollen hormone
02/11/2009CN101361747A Adriablastina freeze-drying preparation with stable albumin and use thereof in treating tumor
02/11/2009CN101361746A Stable adriablastina albumin lipid drug-loading system and preparation method thereof
02/11/2009CN101361743A Use of triazinetrione sulfones for combating coccidiosis
02/11/2009CN101361742A Aminophylline oral solution and preparation method thereof
02/11/2009CN101361739A Anti-bacteria agent for parenteral administration
02/11/2009CN101361731A Docetaxel freeze-drying preparation with stable albumin and use thereof in treating tumor
02/11/2009CN101361723A Improved pharmaceutical compositions
02/11/2009CN101361721A Polydatin dispersible tablets and preparation method and use thereof
02/11/2009CN101361716A Porous microspheres and use thereof in preparing porous microspheres vaccine
02/11/2009CN101361715A Preparation method of drug-carrying hydroxylapatite microspheres and bone cement composite porous microspheres
02/11/2009CN101361713A Curcumin nano crystallization preparation and preparation method thereof
02/11/2009CN101361712A Blood vessel target liposome carrier mediated by fiber forming growth factor receptor and preparation method and use thereof
02/11/2009CN101361711A Dihydroartemisinin emulsion for injection, freeze-dried emulsion and preparation method thereof
02/11/2009CN101361710A Anticancer composition containing tuomatinib
02/11/2009CN101361709A 0Long-acting enrofloxacin injection and preparation method thereof
02/11/2009CN101361705A Anti-cancer sustained release injection containing hexa-decyl choline phosphate
02/11/2009CN101361704A Double sustained release gel injection
02/11/2009CN101361703A Sirolimos sustained and controlled release preparation and preparation method thereof
02/11/2009CN100461310C Double function magnetic fluid and preparing method thereof
02/11/2009CN100460441C Organism degradable star-type structure poly (glycolide-lactide) medicine carrier microsphere and preparation method thereof